PharmaForce International Revenue and Competitors

Reading, PA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • PharmaForce International's estimated annual revenue is currently $6.4M per year.(i)
  • PharmaForce International's estimated revenue per employee is $91,800

Employee Data

  • PharmaForce International has 70 Employees.(i)
  • PharmaForce International grew their employee count by 1% last year.

PharmaForce International's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M5714%N/AN/A
#2
$205.9M14424%N/AN/A
#3
$52.4M4116%N/AN/A
#4
$21.7M1935%N/AN/A
#5
$5.5M603%N/AN/A
#6
$5.1M5610%N/AN/A
#7
$1.1M18-44%N/AN/A
#8
$0.3M50%N/AN/A
#9
$0.1M20%N/AN/A
#10
$2.7M336%N/AN/A
Add Company

What Is PharmaForce International?

PharmaForce International is a business intelligence firm with decades of experience in analyzing the sales, marketing and medical affairs activities of leading pharmaceutical and biotech firms around the globe. PharmaForce offers a portfolio of syndicated benchmarking programs as well as custom research services. Our industry-experienced analysts are veterans of hundreds of projects in both the pharmaceutical and biotech industries. With a database of over 40,000 contacts at all levels of the industry, our analysts can quickly obtain information on sales force deployment, compensation levels, organizational structures, marketing spend and overall commercial and medical strategies for your key competitors through one-on-one interviews and secondary research techniques. Our client base includes both large and small pharmaceutical and biotech companies who know they can rely on our comprehensive analysis to uncover insights that will increase the market share for their key products.

keywords:N/A

N/A

Total Funding

70

Number of Employees

$6.4M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.6M7025%N/A
#2
$14.7M708%N/A
#3
$9.1M70-57%N/A
#4
$13.2M70-20%N/A
#5
$14.3M7120%N/A